Nothing Special   »   [go: up one dir, main page]

FR2717823B1 - Virus recombinants, préparation et utilisation en thérapie génique. - Google Patents

Virus recombinants, préparation et utilisation en thérapie génique.

Info

Publication number
FR2717823B1
FR2717823B1 FR9403411A FR9403411A FR2717823B1 FR 2717823 B1 FR2717823 B1 FR 2717823B1 FR 9403411 A FR9403411 A FR 9403411A FR 9403411 A FR9403411 A FR 9403411A FR 2717823 B1 FR2717823 B1 FR 2717823B1
Authority
FR
France
Prior art keywords
preparation
gene therapy
recombinant viruses
viruses
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9403411A
Other languages
English (en)
Other versions
FR2717823A1 (fr
Inventor
Jean Francois Julien
Jean-Jacques Robert
Marie-Claude Geoffroy
Michel Perricaudet
Emmanuelle Vigne
Jacques Mallet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Gustave Roussy (IGR)
Aventis Pharma SA
Original Assignee
Centre National de la Recherche Scientifique CNRS
Rhone Poulenc Rorer SA
Institut Gustave Roussy (IGR)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Rhone Poulenc Rorer SA, Institut Gustave Roussy (IGR) filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9403411A priority Critical patent/FR2717823B1/fr
Priority to IL11305295A priority patent/IL113052A0/xx
Priority to ZA952286A priority patent/ZA952286B/xx
Priority to MX9604026A priority patent/MX9604026A/es
Priority to KR1019960705265A priority patent/KR100403893B1/ko
Priority to AT95914389T priority patent/ATE320502T1/de
Priority to EP95914389A priority patent/EP0752003B1/fr
Priority to DE69534873T priority patent/DE69534873T2/de
Priority to PCT/FR1995/000342 priority patent/WO1995025805A1/fr
Priority to US08/704,583 priority patent/US20020028212A1/en
Priority to JP7524435A priority patent/JPH09511394A/ja
Priority to EP06004834A priority patent/EP1681354A3/fr
Priority to AU21406/95A priority patent/AU2140695A/en
Priority to CA002184297A priority patent/CA2184297C/fr
Publication of FR2717823A1 publication Critical patent/FR2717823A1/fr
Application granted granted Critical
Publication of FR2717823B1 publication Critical patent/FR2717823B1/fr
Priority to NO963806A priority patent/NO963806L/no
Priority to FI963755A priority patent/FI963755A0/fi
Priority to AU42334/99A priority patent/AU4233499A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9403411A 1994-03-23 1994-03-23 Virus recombinants, préparation et utilisation en thérapie génique. Expired - Lifetime FR2717823B1 (fr)

Priority Applications (17)

Application Number Priority Date Filing Date Title
FR9403411A FR2717823B1 (fr) 1994-03-23 1994-03-23 Virus recombinants, préparation et utilisation en thérapie génique.
ZA952286A ZA952286B (en) 1994-03-23 1995-03-20 Recombinant viruses their preparation and their use in gene therapy
IL11305295A IL113052A0 (en) 1994-03-23 1995-03-20 Recombinant viruses, their preparation and their use in gene therapy
AU21406/95A AU2140695A (en) 1994-03-23 1995-03-21 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
AT95914389T ATE320502T1 (de) 1994-03-23 1995-03-21 Für eine glutamat-dekarboxylase-aktivität kodierende rekombinierende viren
EP95914389A EP0752003B1 (fr) 1994-03-23 1995-03-21 Virus recombinants codant pour une activite glutamate decarboxylase (gad)
DE69534873T DE69534873T2 (de) 1994-03-23 1995-03-21 Für eine glutamat-dekarboxylase-aktivität kodierende rekombinierende viren
PCT/FR1995/000342 WO1995025805A1 (fr) 1994-03-23 1995-03-21 Virus recombinants codant pour une activite glutamate decarboxylase (gad)
MX9604026A MX9604026A (es) 1994-03-23 1995-03-21 Virus recombinantes que codifican para una actividad de glutamato-descarboxilasa (gad).
JP7524435A JPH09511394A (ja) 1994-03-23 1995-03-21 グルタミン酸デカルボキシラーゼ（ｇａｄ）活性をコードする組換えウイルス
EP06004834A EP1681354A3 (fr) 1994-03-23 1995-03-21 Virus recombinants codant pour une activité glutamate décarboxylase (GAD)
KR1019960705265A KR100403893B1 (ko) 1994-03-23 1995-03-21 글루타메이트 디 카르복실라제(gad) 활성을 암호화하는 재조합바이러스
CA002184297A CA2184297C (fr) 1994-03-23 1995-03-21 Virus recombinants codant pour une activite glutamate decarboxylase (gad)
US08/704,583 US20020028212A1 (en) 1994-03-23 1995-03-21 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
NO963806A NO963806L (no) 1994-03-23 1996-09-11 Rekombinante viruser som koder for en glutamat-dekarboksylase (GAD)aktivitet
FI963755A FI963755A0 (fi) 1994-03-23 1996-09-20 Glutamaatti-dekarboksylaasi-aktiivisuutta (GAD-aktiivisuutta) koodaavat yhdistelmä-DNA-tekniset virukset
AU42334/99A AU4233499A (en) 1994-03-23 1999-07-28 Recombinant viruses coding for a glutamate decarboxylase (GAD) activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403411A FR2717823B1 (fr) 1994-03-23 1994-03-23 Virus recombinants, préparation et utilisation en thérapie génique.

Publications (2)

Publication Number Publication Date
FR2717823A1 FR2717823A1 (fr) 1995-09-29
FR2717823B1 true FR2717823B1 (fr) 1996-04-26

Family

ID=9461346

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9403411A Expired - Lifetime FR2717823B1 (fr) 1994-03-23 1994-03-23 Virus recombinants, préparation et utilisation en thérapie génique.

Country Status (2)

Country Link
FR (1) FR2717823B1 (fr)
ZA (1) ZA952286B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102154345B (zh) * 2011-01-18 2012-10-10 江南大学 谷氨酸脱羧酶基因及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270452A (en) * 1988-11-28 1993-12-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Pure glia maturation factor
JP2814529B2 (ja) * 1989-03-16 1998-10-22 味の素株式会社 虚血性脳障害治療薬
US6682906B1 (en) * 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
FR2688514A1 (fr) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
NZ256018A (en) * 1992-09-25 1997-07-27 Rhone Poulenc Rorer Sa Recombinant adenoviral vectors and their use in directing expression and transcription of selected nucleotide sequences in cells of the central nervous system
FR2702152B1 (fr) * 1993-03-03 1995-05-24 Inst Nat Sante Rech Med Virus recombinants et leur utilisation en thérapie génique.

Also Published As

Publication number Publication date
FR2717823A1 (fr) 1995-09-29
ZA952286B (en) 1996-01-09

Similar Documents

Publication Publication Date Title
FR2712603B1 (fr) Virus recombinants, préparation et utilisation en thérapie génique.
FR2716893B1 (fr) Virus recombinants, leur préparation et leur utilisation thérapeutique.
FR2718150B1 (fr) Virus recombinants, préparation et utilisation en thérapie génique.
FR2712602B1 (fr) Virus recombinants, préparation et utilisation en thérapie génique.
DK0595436T3 (da) Porcint respirations- og reproduktionssygdomsvirus, vacciner og viralt dna
FI951138A0 (fi) Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa
FR2725726B1 (fr) Vecteurs viraux et utilisation en therapie genique
AU3824595A (en) Recombinant negative strand RNA virus expression systems and vaccines
FR2707664B1 (fr) Vecteurs viraux et utilisation en thérapie génique.
FR2704234B1 (fr) Virus recombinants, preparation et utilisation en therapie genique.
AU2328397A (en) Recombinant live feline immunodeficiency virus and proviral dna vaccines
NO971495D0 (no) Svekkede virus og fremgangsmåte til deres fremstilling
OA09664A (en) Virus/herbicide-resistance genes, processes for the preparation thereof and the use thereof
FR2717495B1 (fr) Virus recombinants, préparation et utilisation en thérapie génique.
CA2278808A1 (fr) Procedes pour la culture de cellules et la multiplication de virus
FI971275A (fi) Inaktivoidun IVa2-geenin käsittävät epätäydelliset yhdistelmä-DNA-tekniset adenovirukset
FR2717496B1 (fr) Virus recombinants, préparation et utilisation en thérapie génique.
FR2717823B1 (fr) Virus recombinants, préparation et utilisation en thérapie génique.
FR2717497B1 (fr) Virus recombinants, préparation et utilisation en thérapie génique.
FR2725213B1 (fr) Vecteurs viraux et utilisation en therapie genique
FR2726575B1 (fr) Virus recombinants, preparation et utilisation en therapie genique
PL346859A1 (en) Recombinant celo virus and celo virus dna
FR2718749B1 (fr) Vecteurs viraux et utilisation en thérapie génique.
TR199501690A2 (tr) Papaya ringspot virüs replikaz geni.
GB9423663D0 (en) Viral preparations, immunogens, and vaccines

Legal Events

Date Code Title Description
CD Change of name or company name